Michael von Wolff is Head of the Division of Gynaecological Endocrinology and Reproductive Medicine at the Women`s University Hospital, Berne, Switzerland. He has studied and worked in Germany, London, New York and since 2009 in Switzerland. His research focuses on fertility preservation and natural/minimal stimulation IVF, as well as ovarian stimulation and ovarian tissue transplantation.  He established the German-language network of fertility preservation before cytotoxic therapies “FertiPROTEKT” (www.fertiprotekt.com) in 2006. He also founded the ESHRE Task Force on Fertility Preservation, has co-founded the Special Interest Group “Fertility preservation” of European Society of Human Reproduction and Embryology, ESHRE.   Frank Nawroth Prof. Dr. med., was a Senior Physician and Head of the Department of Gynecological Endocrinology and Reproductive Medicine at the University Women's Hospital in Cologne from 1999-2004, and since 2008 has been an Adjunct Professor of Gynecology and Obstetrics there. Since 2010 he has been working at the Center for Infertility, Prenatal Medicine, Endocrinology and Osteology at Barkhof, Hamburg, where he focuses mainly on fertility preservation and treatment of infertility. He has published several books and papers and is a member of the FertiPROTEKT board.

• Before fertility preservation: FertiPROTEKT network.- FertiTOX - a project of FertiPROTKT.- Indication for and against fertility preservation .- Primary versus secondary fertility preservation.- How to use the book .- Fertility preservation – malignant diseases: Breast cancer.- Hodgkin’s lymphoma .- Non-Hodgkin’s lymphoma.- Acute Leukemia.- Bone cancer.- Soft tissue cancer.- Colo-rectal cancer.- Cancer of the central nervous system.- Malignant melanoma.- Ovarian tumors and cancer.- Cervical cancer   .- Endometrial hyperplasia and endometrial cancer.- Pediatric cancer .- Stem cell transplantation.- Testicular cancer .- Fertility preservation – benign diseases: Hematological diseases.- Auto-immune diseases.- Turner syndrome .- Endometriosis .- Transgender .- Fertility preservation – techniques: Ovarian stimulation to collect oocytes.- Cryopreservation of unfertilized and fertilized.- ocytes.- Removal of ovarian tissue .- Transportation, cryopreservation and storage of ovarian tissue .- Transplantation of ovarian tissue .- In vitro Maturation before freezing of ovarian tissue.- GnRH agonists .- Transposition of ovaries.- Transposition of the uterus.- Transplantation of the uterus.- Cryopreservation of sperm and testicular tissue.- Further fertility preservation techniques .- After fertility preservation: Therapy of uterine bleeding during chemotherapy .- Fertility preservation after cancer therapy (Secondary fertility preservation).- Contraception after cancer therapy.- Infertility treatment using cryopreserved gametes and gonadal tissue.- Infertility treatment after chemotherapy and radiotherapy.- Infertility teatment after breast cancer.- Pregnancy after chemotherapy and radiotherapy of the pelvis .- Premature ovarian insufficiency after cancer therapy – Management.

Select Guide Rating

Michael von Wolff is Head of the Division of Gynaecological Endocrinology and Reproductive Medicine at the Women`s University Hospital, Berne, Switzerland. He has studied and worked in Germany, London, New York and since 2009 in Switzerland. His research focuses on fertility preservation and natural/minimal stimulation IVF, as well as ovarian stimulation and ovarian tissue transplantation.  He established the German-language network of fertility preservation before cytotoxic therapies “FertiPROTEKT” (www.fertiprotekt.com) in 2006. He also founded the ESHRE Task Force on Fertility Preservation, has co-founded the Special Interest Group “Fertility preservation” of European Society of Human Reproduction and Embryology, ESHRE.   Frank Nawroth Prof. Dr. med., was a Senior Physician and Head of the Department of Gynecological Endocrinology and Reproductive Medicine at the University Women's Hospital in Cologne from 1999-2004, and since 2008 has been an Adjunct Professor of Gynecology and Obstetrics there. Since 2010 he has been working at the Center for Infertility, Prenatal Medicine, Endocrinology and Osteology at Barkhof, Hamburg, where he focuses mainly on fertility preservation and treatment of infertility. He has published several books and papers and is a member of the FertiPROTEKT board.

• Before fertility preservation: FertiPROTEKT network.- FertiTOX - a project of FertiPROTKT.- Indication for and against fertility preservation .- Primary versus secondary fertility preservation.- How to use the book .- Fertility preservation – malignant diseases: Breast cancer.- Hodgkin’s lymphoma .- Non-Hodgkin’s lymphoma.- Acute Leukemia.- Bone cancer.- Soft tissue cancer.- Colo-rectal cancer.- Cancer of the central nervous system.- Malignant melanoma.- Ovarian tumors and cancer.- Cervical cancer   .- Endometrial hyperplasia and endometrial cancer.- Pediatric cancer .- Stem cell transplantation.- Testicular cancer .- Fertility preservation – benign diseases: Hematological diseases.- Auto-immune diseases.- Turner syndrome .- Endometriosis .- Transgender .- Fertility preservation – techniques: Ovarian stimulation to collect oocytes.- Cryopreservation of unfertilized and fertilized.- ocytes.- Removal of ovarian tissue .- Transportation, cryopreservation and storage of ovarian tissue .- Transplantation of ovarian tissue .- In vitro Maturation before freezing of ovarian tissue.- GnRH agonists .- Transposition of ovaries.- Transposition of the uterus.- Transplantation of the uterus.- Cryopreservation of sperm and testicular tissue.- Further fertility preservation techniques .- After fertility preservation: Therapy of uterine bleeding during chemotherapy .- Fertility preservation after cancer therapy (Secondary fertility preservation).- Contraception after cancer therapy.- Infertility treatment using cryopreserved gametes and gonadal tissue.- Infertility treatment after chemotherapy and radiotherapy.- Infertility teatment after breast cancer.- Pregnancy after chemotherapy and radiotherapy of the pelvis .- Premature ovarian insufficiency after cancer therapy – Management.

Select Guide Rating

Michael von Wolff is Head of the Division of Gynaecological Endocrinology and Reproductive Medicine at the Women`s University Hospital, Berne, Switzerland. He has studied and worked in Germany, London, New York and since 2009 in Switzerland. His research focuses on fertility preservation and natural/minimal stimulation IVF, as well as ovarian stimulation and ovarian tissue transplantation.  He established the German-language network of fertility preservation before cytotoxic therapies “FertiPROTEKT” (www.fertiprotekt.com) in 2006. He also founded the ESHRE Task Force on Fertility Preservation, has co-founded the Special Interest Group “Fertility preservation” of European Society of Human Reproduction and Embryology, ESHRE.   Frank Nawroth Prof. Dr. med., was a Senior Physician and Head of the Department of Gynecological Endocrinology and Reproductive Medicine at the University Women's Hospital in Cologne from 1999-2004, and since 2008 has been an Adjunct Professor of Gynecology and Obstetrics there. Since 2010 he has been working at the Center for Infertility, Prenatal Medicine, Endocrinology and Osteology at Barkhof, Hamburg, where he focuses mainly on fertility preservation and treatment of infertility. He has published several books and papers and is a member of the FertiPROTEKT board.

• Before fertility preservation: FertiPROTEKT network.- FertiTOX - a project of FertiPROTKT.- Indication for and against fertility preservation .- Primary versus secondary fertility preservation.- How to use the book .- Fertility preservation – malignant diseases: Breast cancer.- Hodgkin’s lymphoma .- Non-Hodgkin’s lymphoma.- Acute Leukemia.- Bone cancer.- Soft tissue cancer.- Colo-rectal cancer.- Cancer of the central nervous system.- Malignant melanoma.- Ovarian tumors and cancer.- Cervical cancer   .- Endometrial hyperplasia and endometrial cancer.- Pediatric cancer .- Stem cell transplantation.- Testicular cancer .- Fertility preservation – benign diseases: Hematological diseases.- Auto-immune diseases.- Turner syndrome .- Endometriosis .- Transgender .- Fertility preservation – techniques: Ovarian stimulation to collect oocytes.- Cryopreservation of unfertilized and fertilized.- ocytes.- Removal of ovarian tissue .- Transportation, cryopreservation and storage of ovarian tissue .- Transplantation of ovarian tissue .- In vitro Maturation before freezing of ovarian tissue.- GnRH agonists .- Transposition of ovaries.- Transposition of the uterus.- Transplantation of the uterus.- Cryopreservation of sperm and testicular tissue.- Further fertility preservation techniques .- After fertility preservation: Therapy of uterine bleeding during chemotherapy .- Fertility preservation after cancer therapy (Secondary fertility preservation).- Contraception after cancer therapy.- Infertility treatment using cryopreserved gametes and gonadal tissue.- Infertility treatment after chemotherapy and radiotherapy.- Infertility teatment after breast cancer.- Pregnancy after chemotherapy and radiotherapy of the pelvis .- Premature ovarian insufficiency after cancer therapy – Management.

Select Guide Rating